TherapeuticsMD (TXMD) Net Margin Growth (3y) (2014 - 2026)
TherapeuticsMD (TXMD) Net Margin Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 3,662.00 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -98.00 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -1,235.00 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 11,401.00 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 4,252.00 |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -404.00 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -15,806.00 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -987.00 |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 3,232.00 |
| 10 | TherapeuticsMD | 21,180.42 | -8.40 Mn | - | 30,971.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30,971.00 |
| Dec 31, 2025 | -4,344.00 |
| Sep 30, 2025 | 406,216.00 |
| Jun 30, 2025 | -3.65 Mn |
| Mar 31, 2025 | 447,711.00 |
| Dec 31, 2024 | -24,781.00 |
| Sep 30, 2024 | 17,897.00 |
| Jun 30, 2024 | 16,834.00 |
| Mar 31, 2024 | 22,220.00 |
| Dec 31, 2023 | 31,748.00 |
| Sep 30, 2023 | -349,932.00 |
| Mar 31, 2023 | 15,322.00 |
| Dec 31, 2022 | 35,353.00 |
| Sep 30, 2022 | -391,438.00 |
| Jun 30, 2022 | 3.74 Mn |
| Mar 31, 2022 | -348,052.00 |
| Dec 31, 2021 | 104,254.00 |
| Sep 30, 2021 | 83,826.00 |
| Jun 30, 2021 | 69,735.00 |
| Mar 31, 2021 | 44,851.00 |